Table 6. Regimen, duration, and adherence of first-line ART.
ART: Antiretroviral therapy; ALE: Abacavir + Lamivudine + Efavirenz; TLE: Tenofovir + Lamivudine + Efavirenz; TLN: Tenofovir + Lamivudine + Nevirapine; ZLE: Zidovudine + Lamivudine + Efavirenz; ZLN: Zidovudine + Lamivudine + Nevirapine.
| Variables | Categories | No of patients (%) |
| ART regimen | ALE | 6 (6.7) |
| TLE | 49 (54.5) | |
| TLN | 2 (2.2) | |
| ZLE | 3 (3.3) | |
| ZLN | 30 (33.3) | |
| Duration of first-line ART (months) | 6-12 | 0 (0.0) |
| 12-18 | 10 (11.1) | |
| 18-24 | 16 (17.8) | |
| 24-30 | 38 (42.2) | |
| 30-36 | 5 (5.6) | |
| 36-42 | 2 (2.2) | |
| 42-48 | 2 (2.2) | |
| >48 | 17 (18.9) | |
| Adherence (%) | >95 | 30 (33.3) |
| 90-95 | 22 (24.4) | |
| <90 | 38 (42.2) |